SCHEMBL11901003

SCHEMBL11901003

O=C(NCc1ccccc1)c1ccccc1C(=O)NCc1ccccc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.89
APEX1 P27695 1/20 0.81
HPGD P15428 3/20 0.76
GAA P10253 2/20 0.76
LMNA P02545 1/20 0.76
L3MBTL1 Q9Y468 1/20 0.76
METAP2 P50579 1/20 0.73
CHRNB2 P17787 1/20 0.73
CHRNB4 P30926 1/20 0.73
CHRNA3 P32297 1/20 0.73
CHRNA4 P43681 1/20 0.73
CYP2C19 P33261 2/20 0.69
TP53 P04637 1/20 0.69
GLA P06280 1/20 0.69
CYP1A2 P05177 1/20 0.69
NSD2 O96028 3/20 0.67
SGMS2 Q8NHU3 1/20 0.67
USP2 O75604 1/20 0.63
CYP3A4 P08684 1/20 0.62
CYP2C9 P11712 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31680569 1.00 KMT2A (0.89) KMT2AAPEX1HPGDGAALMNA
SCHEMBL1984940 0.94 KMT2A (1.00) KMT2AAPEX1HPGDGAALMNA
SCHEMBL8635709 0.94 KMT2A (1.00) KMT2AAPEX1HPGDGAALMNA
SCHEMBL9853965 0.91 KMT2A (0.74) KMT2AAPEX1HPGDGAALMNA
SCHEMBL1979028 0.88 KMT2A (0.71) KMT2AAPEX1HPGDGAALMNA
SCHEMBL7183285 0.88 KMT2A (0.71) KMT2AAPEX1HPGDGAALMNA
SCHEMBL12181631 0.87 ALDH1A1 (0.74) KMT2AAPEX1HPGDGAALMNA
SCHEMBL5312965 0.87 KMT2A (0.69) KMT2AAPEX1HPGDGAALMNA
SCHEMBL6403159 0.87 KMT2A (0.69) KMT2AAPEX1HPGDGAALMNA
SCHEMBL17686276 0.87 HPGD (1.00) KMT2AAPEX1HPGDGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372915-A1 MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2023-11-23 US disclosed
US-11731116-B2 Manganese based complexes and uses thereof for homogeneous catalysis YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2023-08-22 US disclosed
EP-3919466-A1 MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS Yeda Research and Development Co. Ltd (IL) 2021-12-08 EP disclosed
US-20150140588-A1 Lipase Variants and Polynucleotides Encoding Same NOVOZYMES A/S (DK) 2015-05-21 US disclosed
US-8377530-B2 Polyesters with low molecular weight additives for improved gas barrier properties EASTMAN CHEMICAL COMPANY (US) 2013-02-19 US disclosed
US-20120199515-A1 POLYESTERS WITH LOW MOLECULAR WEIGHT ADDITIVES FOR IMPROVED GAS BARRIER PROPERTIES EASTMAN CHEMICAL COMPANY (US) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230372915-A1 MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS ADH1C, OTC, MLEC KMT2A 843/4885APEX1 1048/4885HPGD 2241/4885
US-11731116-B2 Manganese based complexes and uses thereof for homogeneous catalysis ADH1C, OTC, ADH5 KMT2A 990/4885APEX1 996/4885HPGD 2313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.